Embryonic Lethality, Decreased Erythropoiesis, and Defective Octamer-Dependent Promoter Activation in Oct-1-Deficient Mice

Molecular and Cellular Biology

Volumn 24, Issue 3, 2004, Pages 1022-1032

  Wang, Victoria E H ^a   Schmidt, Tara ^a   Chen, Jianzhu ^a   Sharp, Phillip A ^a,b   Tantin, Dean ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 1; OCTAMER TRANSCRIPTION FACTOR 2; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL STRAIN 3T3; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; ERYTHROPOIESIS; FEMALE; GENE ACTIVATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; DNA-BINDING PROTEINS; EMBRYO LOSS; ERYTHROPOIESIS; GENE TARGETING; GENES, LETHAL; GLOBINS; HETEROZYGOTE; HOST CELL FACTOR C1; MICE; MUTATION; OCTAMER TRANSCRIPTION FACTOR-1; OCTAMER TRANSCRIPTION FACTOR-2; PROMOTER REGIONS (GENETICS); SEQUENCE ANALYSIS, DNA; TRANSCRIPTION FACTORS;

ANIMALIA; MAMMALIA;

EID: 1242303895     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.3.1022-1032.2004     Document Type: Article

References (69)

1. Bharadwaj, R. R., C. D. Trainor, P. Pasceri, and J. Ellis. 2003. LCR-regulated transgene expression levels depend on the Oct-1 site in the AT-rich region of beta-globin intron-2. Blood 101:1603-1610.
2. Boutet, S. C., T. Quertermous. and B. M. Fadel. 2001. Identification of an octamer element required for in vivo expression of the TIEI gene in endothelial cells. Biochem. J. 360:23-29.
3. Casellas, R., M. Jankovic, G. Meyer, A. Gazumyan, Y. Lou, R. Roeder, and M. Nussenzweig. 2002. OcaB is required for normal transcription and V(D)J recombination of a subset of immunoglobulin kappa genes. Cell 110:575-585.
4. Cepek, K. L., D. I. Chasman, and P. A. Sharp. 1996. Sequence-specific DNA binding of the B-cell-specific coactivator OCA-B. Genes Dev. 10:2079-2088.
5. Christensen, S. M., B. K. Martin, S. S. Tan, and J. H. Weis. 1992. Identification of sites for distinct DNA binding proteins including Oct-1 and Oct-2 in the Cr2 gene. J. Immunol. 148:3610-3617.
6. Clerc, R. G., L. M. Corcoran, J. H. LeBowitz, D. Baltimore, and P. A. Sharp. 1988. The B-cell-specific Oct-2 protein contains POU box- and homco box-type domains. Genes Dev. 2:1570-1581.
7. Corenran, L. M., M. Karvelas, G. J. Nossal, Z. S. Ve, T. Jacks, and D. Baltimore. 1993. Oct-2, although not required for early B-cell development. is critical for later B-cell maturation and for postnatal survival. Genes Dev. 7:5711-582.
8. Dignam, J. D., R. M. Lehovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase 11 in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475-1489.
9. Erkman, L., R. J. McEvilly, L. Lou, A. K. Ryan, F. Hooshmand, S. M. O'Connell, E. M. Keithley, D. H. Rapaport, A. F. Ryan and M. G. Rosentkhl. 1996. Role of transcription factors Brn-3.1 and Bm-3.2 in auditory and visual system development. Nature 381:603-606.
10. Falkner, F. G., and H. G. Zachan. 1984. Correct transcription of an immunoglobulin kappa gene requires an upstream fragment containing conserved sequence elements. Nature 310:71-74.
11. Fan, W., S. Jin, T. Tong, H. Zhao, F. Fan, M. J. Antinore, B. Rajasekaran, M. Wu, and Q. Zhan, 2002. BRCA1 regulates GADD45 through its interactions with the OCT-1 mid CAAT motifs. J. Biol. Chem. 277:8061-8067.
12. Gstaiger, M., L. Knoepfel, O. Georgiev, W. Schaffner, and C. M. Hovens. 1995. A B-cell coactivator of octamer-binding transcription factors. Nature 373:360-362.
13. Gunderson, S. I., J. T. Murphy, M. W. Knuth, T. H. Steinberg, J. H. Dahlberg, and R. R. Burgess. 1988. Binding of transcription flitters to the promoter of the human U1 RNA gene studied by footprinting. J. Biol. Chem. 263:17603-17610.
14. Handa, H., Y. Yamaguchi, and T. Wada. 1999. Purification of DNA-binding proteins, p. 283-302. In P. Millner (ed.), High resolution chromatography: a practical approach. Oxford University Press, Oxford, England.
15. Hernandez, N. 2001. Small nuclear RNA genes: a model system to study fundamental mechanisms of transcription. J. Biol. Chem. 276:26733-26736.
16. Herr, W., R. A. Sturm, R. G. Clerc, L. M. Corcoran, D. Baltimore, P. A. Sharp, H. A. Ingraham, M. G. Rosenfeld, M. Finney, G. Ruvkun, et al. 1988. The POU domain: a large conserved region in the mammalian pi1-I, oct-1, oct-2, and Caenorhabditis elegans unc-86 gene products. Genes Dev 2:1513-1516.
17. Horwitz, B. H., M. L. Scott, S. R. Cherry, R. T. Bronson, and D. Baltimore. 1997. Failure of lymphopoiesis after adoptive transfer of NF-kappaB-deficient fetal liver cells. Immunity 6:765-772.
18. Humbert, P. O., R. Verona, J. M. Trimarchi, C. Rogers, S. Dandapani, and J. A. Lees. 2000. E2f3 is critical for normal cellular proliferation. Genes Dev. 14:690-703.
19. Jaffe, J., M. Hochberg, J. Riss, T. Hasin, L. Reich, and R. Laskov. 1995. Cloning, sequencing and expression of two isoforms of the murine oct-1 transcription factor. Biochim. Biophys. Acta 1261:201-209.
20. Jenuweim T., and R. Grosschedl. 1991. Complex pattern of immunologlobulin mu gene expression in normal and transgenic mice: nonoverlapping regulatory sequences govern distinct tissue specificities. Genes Dev. 5:932-943.
21. Jin, S., F. Fan, W. Fan, H. Zhao, T. Tong, P. Blanck, I. Alomo, B. Rajasekaran, and Q. Zhan. 2001. Transcription factor's Oct-1 and NF-YA regulate the p53-independent induction of the GADD45 following DNA damage. Oncogene 20:2683-2690.
22. Jin, T., and H. Li. 2001. Pou homeodomain protein OCTI is implicated in the expression of the caudal-related homeobox gene Cdx-2. J. Biol. Chem. 276:14752-14758.
23. Kamps, M. P., L. Corcoran, J. H. LeBowitz. and D. Baltimore. 1990. The promoter of the human interleukin-2 gene contains two octamer-binding sites and is partially activated by the expression of Oct-2. Mol. Cell. Biol. 10:5464-5472.
24. Kim, U., X. F. Qin, S. Gong, S. Stevens, Y. Lou, M. Nussenzweig, and R. G. Roeder. 1996. The B-cell-specific transcription coactivator OCA-B/OBF-1/ Bob-1 is essential for normal production of immunoglobulin isotypes. Nature 383:542-547.
25. Kiln, Y. M., C. B. Ko, Y. P. Park, Y. J. Kim, and S. G. Paik. 1999. Octamer motif is required for the NF-kappaB-mediated induction of the inducible nitric oxide synthase gene expression in RAW 264.7 macrophages. Mol. Cell 9:99-109.
26. Klemm, J. D., M. A. Rould, R. Aurora, W. Herr, and C. O. Paho. 1994. Crystal structure of the Oct-1 POU domain bound to an octamer site: DNA recognition with tethered DNA-binding modules. Cell 77:21-32.
27. Konig, H., P. Pfisterer, L. M. Corcoran, and T. Wirth. 1995. Identification of CD36 as the first gene dependent on the B-cell differentiation factor Oct-2. Genes Dev. 9:1598-1607.
28. Koyasu, S., R. E. Hussey, L. K. Clayton, A. Lerner, R. Pedersen, P. Delany-Heiken, F. Chau, and E. L. Reinherz. 1994. Targeted disruption within the CD3 zeta/eta/phi/Oct-1 locus in mouse. EMBO J. 13:784-797.
29. LeBowitz. J. H., T. Kobayashi, L. Staudt, D. Baltimore, and P. A. Sharp. 1988. Octamer-binding proteins from B or HeLa cells stimulate transcription of the immunoglobulin heavy-chain promoter in vitro. Genes Dev. 2:1227-1237.
30. Lefort, K., J. P. Rouault, L. Tondereau, J. P. Magaud, and J. F. Dore. 2001. Thc specific activation of gadd45 following UVB radiation requires the POU family gene product N-oct3 in human melanoma cells. Oncogene 20:7375-7385.
31. Lerner, A., L. D'Adamio, A. C. Diener, L. K. Clayton, and E. L. Reinherz. 1993. CD3 zetu/eta/theta locus is colinear with and transcribed antisense to the gene encoding the transcription factor Oct-1. J. Immunol. 151:3152-3162.
32. Li, E., T. H. Bestor, and R. Jaenisch. 1992. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69:915-926.
33. Li, S., E. B. Crenshaw, 3rd, E. J. Rawson, D. M. Simmons, L. W. Swanson, and M. G. Rosenfeld. 1990. Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU domain gene pit-1. Nature 347:528-533.
34. Lopez, R. A., S. Schoetz, K. DeAngelis, D. O'Neill, and A. Bank. 2002. Multiple hematopoietic defects and delayed globin switching in Ikaros null mice. Proc. Natl. Acid. Sci. USA 99:602-607.
35. Luo, Y, and R. G. Roeder. 1995. Cloning, functional characterization, and mechanism of action of the B-cell-specific transcriptional coactivator OCA-B. Mol. Cell. Biol. 15:4115-4124.
36. Mahmoud, M. S., and M. M. Kawano. 1996. Cloning and analysis of the human Pax-5 gene promoter. Biochem. Biophys. Res. Commun. 228:159-164.
37. Masun, J. O., G. T. Williams, and M. S. Neuherger. 1985. Transcription cell type specificity is conferred by an immunoglobulin VH gene promoter that includes a functional concensus sequence. Cell 41:479-487.
38. Murphy, J. T., R. R. Burgess, J. E. Dahlherg, and E. Lund. 1982. Transcription of a gene for human U1 small nuclear RNA. Cell 29:265-274.
39. Nichols, J., B. Zevnik, K. Anastassiadis, H. Niwa, D. Klewe-Nebenius, I. Chamhers, H. Schuler, and A. Smith. 1998. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95:379-391.
40. Nielsen, P. J., O. Georgiev, B. Lorenz, and W. Schaffner. 1996. B lymphocytes tire impaired in mice lacking the transcriptional coactivator Bob1/ OCA-B/OBF1. Eur. J. Immunol. 26:3214-3218.
41. Ohno, H., S. Goto, S. Taki, T. Shirasawa, H. Nakano, S. Miyatake, T. Aoe, Y. Ishida, H. Maeda, T. Shirai, and et al. 1994. Targeted disruption of the CD3 eta locus causes high lethality in mice: modulation of Oct-1 transcription on the opposite strand. EMBO J. 13:1157-1165.
42. Pankratova, E. V., I. E. Deyev, S. V. Zhenilo, and O. L. Polanovsky. 2001. Tissue-specific isoforms of the ubiquitous transcription factor Oct-1. Mol. Genet. Genomics 266:239-245.
43. Parslow, T. G., D. L. Blair, W. J. Murphy, and D. K. Granner. 1984. Structure of the 5′ ends of immunoglobulin genes: a novel conserved sequence. Proc. Natl. Acad. Sci. USA 81:2650-2654.
44. Pfaffle, R. W., G. E. DiMattia, J. S. Parks, M. R. Brown, J. M. Wit, M. Jansen, H. Van der Nat, J. L. Van den Brande, M. G. Rosenfeld, and H. A. Ingraham. 1992. Mutation of the POU-specific domain of Pit-1 and hypopituitarism without pituitary hypoplasia. Science 257:1118-1121.
45. Pfeuffer, I., S. Klein-Hessling, A. Heinfling, S. Chuvpilo, C. Escher, T. Brabletz, B. Hentsch, H. Schwarzenbach, P. Matthias, and E. Serfling. 1994. Octamer factors exert a dual effect on the interleukin-2 and interleukin-4 promoters. J. Immunol. 153:5572-5585.
46. Plisterer, P., J, Hess, and T. Wirth. 1997. Identification of target genes of the lymphoid-specific transcription factor Oct2. Immunobiology 198:217-226.
47. Riss, J., and R. Laskov. 1999. Expression of novel alternatively spliced isoforms of the oct-1 transcription factor. Biochim. Biophys. Acta 1444:295-298.
48. Rubin, J. E., P, Pasceri, X. Wu, P. Leboulch, and J. Ellis, 2000. Locus control region activity by 5′HS3 requires a functional interaction with beta-glohin gene regulator, elements: expression of novel beta/gamma-globin hybrid transgenes. Blood 95:3242-3249.
49. Ryan, A. K., and M. G. Rosenfeld. 1997. POU domain family values: flexibility, partnerships, and developmental codes. Genes Dev. 11:1207-1225.
50. Scheidereit, C., J. A. Cromlish, T. Gerster, K. Kawakami, C. G. Balmaceda, R. A. Currie, and R. G. Roeder. 1988. A human lymphoid-specific transcription factor that activates immunoglobulin genes is a homoeobox protein. Nature 336:551-557.
51. Schuhart, K., S. Massa, D. Schubart, L. M. Corcoran, A. G. Rolink, and P. Matthias. 2001. B-cell development and immunoglobulin gene transcription in the absence of Oct-2 and OBF-1. Nat. Immunol. 2:69-74.
52. Shehee, W. R., P. Oliver, and O. Smithies. 1993. Lethal thalassemia after insertional disruption of the mouse major adult beta-globin gene. Proc. Natl. Acad. Sci. USA 90:3177-3181.
53. Shore, P., W. Dietrich, and L. M. Corcoran. 2002. Oct-2 regulates CD36 gene expression via a concensus octamer, which excludes the co-activator OBF-1. Nucleic Acids Res. 30:1767-1773.
54. Singh, H., R. Sen, D. Baltimore, and P. A. Sharp. 1986. A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes. Nature 319:154-158.
55. Stye, H. L., and R. G. Roeder. 1986. Interaction of a common factor with conserved promoter and enhancer sequences in histone H2B, immunoglobulin, and U2 small nuclear RNA (snRNA) genes. Proc. Natl. Acad. Sci. USA 83:6382-6386.
56. Skow, L. C., B. A. Burkhart, F. M. Johnson, R. A. Popp, D. M. Popp, S. Z. Goldberg, W. F. Anderson, L. B. Barnett, and S. E. Lewis. 1983. A mouse model for beta-thalassemia. Cell 34:1043-1052.
57. Staudt, L. M., H. Singh, R. Sen, T. Wirth, P. A. Sharp, and D. Baltimore. 1986. A lymphoid-specific protein binding to the octamer motif of immunoglobulin genes. Nature 323:640-643.
58. Strubin, M., J. W. Newell, and P. Matthias. 1995. OBF-1, a novel B-cell-specific coactivator that stimulates immunoglobulin promoter activity through association with octamer-binding proteins. Cell 80:497-506.
59. Sturm, R. A., J. L. Cassady, G. Das, A. Romo, and G. A. Evans. 1993. Chromosomal structure and expression of the human OTF1 locus encoding the Oct-1 protein. Genomics 16:333-341.
60. Sturm, R. A., and W. Herr. 1988. The POU domain is a bipartite DNA-binding structure. Nature 336:601-604.
61. Takahashi, S., S. Saito, N. Ohtani, and T. Sakai. 2001. Involvement of the Oct-1 regulatory element of the gadd45 promoter in the p53-independcnt response to ultraviolet irradiation. Cancer Res. 61:1187-1195.
62. Tantin, D., and P. A. Sharp. 2002. A Mouse lymphoid cell line selected to have high immunoglobulin promoter activity. Mol. Cell. Biol. 22:1460-1473.
63. Thevenin, C., B. P. Lucas, E.J. Kozlow, and J. H. Kehrl. 1993. Cell type- and stage-specific expression of the CD20/B1 antigen correlates with the activity of a diverged octamer DNA motif present in its promoter. J. Biol. Chem. 268:5949-5956.
64. Todaro, G., and H. Green. 1963. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J. Cell Biol. 17:299-313.
65. Trimborn, T., J. Gribnau, F. Grosveld, and P. Fraser, 1999. Mechanisms of developmental control of transcription in the murine alpha- and beta-globin loci. Genes Dev. 13:112-124.
66. Verrijzer, C. P., M. J. Alkema, W. W. van Weperen, H. C. Van Leeuwen, M. J. Strating, and P. C. van der Vliet. 1992. The DNA binding specificity of the bipartite POU domain and its subdomains. EMBO J. 11:4993-5003.
67. Wang, D., S. Yamamoto, N. Hijiya, E. N. Benveniste, and C. L. Gladson. 2000. Transcriptional regulation of the human osteopontin promoter: functional analysis and DNA-protein interactions. Oncogene 19:5801-5809.
68. Yang, B., S. Kirby, J. Lewis, P. J. Detloff, N. Maeda, and O. Smithies. 1995. A mouse model for beta 0-thalassemia. Proc. Natl. Acad. Sci. USA 92: 11605-11612.
69. Zhang, L., and G. J. Nabel. 1994. Positive and negative regulation of interleukin-2 gene expression: role of multiple regulatory sites. Cytokine 6:221-228.